Teratogenicity and neonatal toxicity of clindamycin 2-phosphate in laboratory animals.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D000831:Animals, Newborn; D001663:Bilirubin / Q000097:blood; D001724:Birth Weight / Q000187:drug effects; D002972:Cleft Palate / Q000139:chemically induced; D002981:Clindamycin / Q000633:toxicity*; D005260:Female; D006933:Hyperbilirubinemia, Hereditary / Q000378:metabolism; D007928:Lethal Dose 50; D051379:Mice; D008813:Mice, Inbred ICR; D010710:Phosphates / Q000633:toxicity; D011247:Pregnancy; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000378:metabolism; D013997:Time Factors; D014803:Vitamin B Complex / Q000494:pharmacology
D010710:Phosphates; D012709:Serum Albumin; D014803:Vitamin B Complex; D002981:Clindamycin; D001663:Bilirubin